Continuous Glucose Monitoring System in Acromegalic Patients: Possible Role in the Assessment of Glycemia Control.

Valeria MercuriTania D'AmicoDenise CostaCorrado De VitoLuca D'AngeloRiccardo Schiaffini Patrizia Gargiulo

Published in: Journal of diabetes science and technology (2020)

Our results show a significantly higher response in terms of mean and peak OGTT in patients treated with SSA, both compared to the CGM study, and compared to the group of patients receiving pegvisomant. The CGM system could represent an instrument for the evaluation of the glycemic trend of acromegalic patients.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
type diabetes
prognostic factors
patient reported outcomes
metabolic syndrome
skeletal muscle
insulin resistance